{"transactions":[{"id":3074483,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":106747,"kind":"organization","name":"TPG Group Holdings (SBS) Advisors, Inc.","position":1,"cik":"0001495741","reported_name":"TPG Group Holdings (SBS) Advisors, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}},{"id":136573,"kind":"organization","name":"TPG Advisors VI, Inc.","position":2,"cik":"0001433038","reported_name":"TPG Advisors VI, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}},{"id":147565,"kind":"organization","name":"TPG Advisors V, Inc.","position":3,"cik":"0001425876","reported_name":"TPG Advisors V, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}},{"id":147566,"kind":"organization","name":"TPG Biotech Advisors, Inc.","position":4,"cik":"0001666545","reported_name":"TPG Biotech Advisors, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}},{"id":85655,"kind":"person","name":"BONDERMAN DAVID","position":5,"cik":"0000860866","reported_name":"BONDERMAN DAVID","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}},{"id":24314,"kind":"person","name":"COULTER JAMES G","position":6,"cik":"0001099776","reported_name":"COULTER JAMES G","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Common Stock","published_at":"2020-07-29T16:42:45.000Z","date":"2020-07-28","kind":"sale","acquired":false,"shares":2919051,"price":159.12,"value":464479395.12,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. (\"Group Advisors\"), (ii) TPG Advisors VI, Inc. (\"Advisors VI\"), (iii) TPG Advisors V, Inc. (\"Advisors V\") and (iv) TPG GP Advisors, Inc. (as successor to TPG Biotech Advisors, Inc.) (\"TPG GP Advisors\" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Group Advisors is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC. TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., (ii) TPG FOF V-A, L.P. and (iii) TPG FOF V-B, L.P. TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P. Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P. and (ii) managing member of TPG Iceberg Co-Invest LLC. Advisors V is the general partner of TPG Quintiles Holdco II, L.P. TPG GP Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the \"TPG Funds\"). Each of the TPG Funds directly held shares of Common Stock of IQVIA Holdings Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may have been deemed to have beneficially owned the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds. Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001387131-20-006834","document":"iqv-form4_072820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860866/000138713120006834/iqv-form4_072820.xml","form_type":"4"}},{"id":3268397,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":106747,"kind":"organization","name":"TPG Group Holdings (SBS) Advisors, Inc.","position":1,"cik":"0001495741","reported_name":"TPG Group Holdings (SBS) Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":136573,"kind":"organization","name":"TPG Advisors VI, Inc.","position":2,"cik":"0001433038","reported_name":"TPG Advisors VI, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":147565,"kind":"organization","name":"TPG Advisors V, Inc.","position":3,"cik":"0001425876","reported_name":"TPG Advisors V, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":147566,"kind":"organization","name":"TPG Biotech Advisors, Inc.","position":4,"cik":"0001666545","reported_name":"TPG Biotech Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":85655,"kind":"person","name":"BONDERMAN DAVID","position":5,"cik":"0000860866","reported_name":"BONDERMAN DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":24314,"kind":"person","name":"COULTER JAMES G","position":6,"cik":"0001099776","reported_name":"COULTER JAMES G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-18T19:00:43.000Z","date":"2020-02-13","kind":"sale","acquired":false,"shares":2996172,"price":164.3,"value":492271059.6,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. (\"Group Advisors\"), (ii) TPG Advisors VI, Inc. (\"Advisors VI\"), (iii) TPG Advisors V, Inc. (\"Advisors V\") and (iv) TPG Biotech Advisors, Inc. (\"Biotech Advisors\" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Group Advisors is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC. TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., which directly holds 1,043,851 shares of Common Stock (\"Common Stock\") of IQVIA Holdings Inc. (the \"Issuer\"), (ii) TPG FOF V-A, L.P., which directly holds 2,731 shares of Common Stock, and (iii) TPG FOF V-B, L.P., which directly holds 2,202 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P., which directly holds 1,044,654 shares of Common Stock. TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P., which directly holds 43,101 shares of Common Stock. Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P., which directly holds 4,129 shares of Common Stock, and (ii) managing member of TPG Iceberg Co-Invest LLC, which directly holds 359,173 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Advisors V is the general partner of TPG Quintiles Holdco II, L.P., which directly holds 398,364 shares of Common Stock. Biotech Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the \"TPG Funds\"), which directly holds 20,846 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds. Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":2919051,"source":{"system":"sec-edgar","filing":"0001387131-20-001902","document":"iqv-form4_021320.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860866/000138713120001902/iqv-form4_021320.xml","form_type":"4"}},{"id":3441700,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":106747,"kind":"organization","name":"TPG Group Holdings (SBS) Advisors, Inc.","position":1,"cik":"0001495741","reported_name":"TPG Group Holdings (SBS) Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":136573,"kind":"organization","name":"TPG Advisors VI, Inc.","position":2,"cik":"0001433038","reported_name":"TPG Advisors VI, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":147565,"kind":"organization","name":"TPG Advisors V, Inc.","position":3,"cik":"0001425876","reported_name":"TPG Advisors V, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":147566,"kind":"organization","name":"TPG Biotech Advisors, Inc.","position":4,"cik":"0001666545","reported_name":"TPG Biotech Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":85655,"kind":"person","name":"BONDERMAN DAVID","position":5,"cik":"0000860866","reported_name":"BONDERMAN DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":24314,"kind":"person","name":"COULTER JAMES G","position":6,"cik":"0001099776","reported_name":"COULTER JAMES G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-12T17:00:08.000Z","date":"2019-08-08","kind":"sale","acquired":false,"shares":2616028,"price":156.85,"value":410323991.8,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. (\"Group Advisors\"), (ii) TPG Advisors VI, Inc. (\"Advisors VI\"), (iii) TPG Advisors V, Inc. (\"Advisors V\") and (iv) TPG Biotech Advisors, Inc. (\"Biotech Advisors\" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Group Advisors is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC. TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., which directly holds 2,115,281 shares of Common Stock (\"Common Stock\") of IQVIA Holdings Inc. (the \"Issuer\"), (ii) TPG FOF V-A, L.P., which directly holds 5,534 shares of Common Stock, and (iii) TPG FOF V-B, L.P., which directly holds 4,462 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P., which directly holds 2,116,908 shares of Common Stock. TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P., which directly holds 87,340 shares of Common Stock. Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P., which directly holds 8,368 shares of Common Stock, and (ii) managing member of TPG Iceberg Co-Invest LLC, which directly holds 727,835 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Advisors V is the general partner of TPG Quintiles Holdco II, L.P., which directly holds 807,253 shares of Common Stock. Biotech Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the \"TPG Funds\"), which directly holds 42,242 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds. Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":5915223,"source":{"system":"sec-edgar","filing":"0000903423-19-000311","document":"iqvia.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860866/000090342319000311/iqvia.xml","form_type":"4"}},{"id":3600531,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":106747,"kind":"organization","name":"TPG Group Holdings (SBS) Advisors, Inc.","position":1,"cik":"0001495741","reported_name":"TPG Group Holdings (SBS) Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":136573,"kind":"organization","name":"TPG Advisors VI, Inc.","position":2,"cik":"0001433038","reported_name":"TPG Advisors VI, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":147565,"kind":"organization","name":"TPG Advisors V, Inc.","position":3,"cik":"0001425876","reported_name":"TPG Advisors V, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":147566,"kind":"organization","name":"TPG Biotech Advisors, Inc.","position":4,"cik":"0001666545","reported_name":"TPG Biotech Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":85655,"kind":"person","name":"BONDERMAN DAVID","position":5,"cik":"0000860866","reported_name":"BONDERMAN DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":24314,"kind":"person","name":"COULTER JAMES G","position":6,"cik":"0001099776","reported_name":"COULTER JAMES G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-12T16:18:33.000Z","date":"2019-03-08","kind":"sale","acquired":false,"shares":4044480,"price":140.8,"value":569462784.0,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. (\"Group Advisors\"), (ii) TPG Advisors VI, Inc. (\"Advisors VI\"), (iii) TPG Advisors V, Inc. (\"Advisors V\") and (iv) TPG Biotech Advisors, Inc. (\"Biotech Advisors\" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Group Advisors is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC. TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., which directly holds 3,050,771 shares of Common Stock (\"Common Stock\") of IQVIA Holdings Inc. (the \"Issuer\"), (ii) TPG FOF V-A, L.P., which directly holds 7,981 shares of Common Stock, and (iii) TPG FOF V-B, L.P., which directly holds 6,435 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P., which directly holds 3,053,120 shares of Common Stock. TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P., which directly holds 125,967 shares of Common Stock. Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P., which directly holds 12,069 shares of Common Stock, and (ii) managing member of TPG Iceberg Co-Invest LLC, which directly holds 1,049,722 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Advisors V is the general partner of TPG Quintiles Holdco II, L.P., which directly holds 1,164,263 shares of Common Stock. Biotech Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the \"TPG Funds\"), which directly holds 60,923 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds. Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":8531251,"source":{"system":"sec-edgar","filing":"0000903423-19-000147","document":"iqvia.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860866/000090342319000147/iqvia.xml","form_type":"4"}},{"id":3742465,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":106747,"kind":"organization","name":"TPG Group Holdings (SBS) Advisors, Inc.","position":1,"cik":"0001495741","reported_name":"TPG Group Holdings (SBS) Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":136573,"kind":"organization","name":"TPG Advisors VI, Inc.","position":2,"cik":"0001433038","reported_name":"TPG Advisors VI, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":147565,"kind":"organization","name":"TPG Advisors V, Inc.","position":3,"cik":"0001425876","reported_name":"TPG Advisors V, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":147566,"kind":"organization","name":"TPG Biotech Advisors, Inc.","position":4,"cik":"0001666545","reported_name":"TPG Biotech Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":85655,"kind":"person","name":"BONDERMAN DAVID","position":5,"cik":"0000860866","reported_name":"BONDERMAN DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":24314,"kind":"person","name":"COULTER JAMES G","position":6,"cik":"0001099776","reported_name":"COULTER JAMES G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-06T16:35:16.000Z","date":"2018-12-04","kind":"sale","acquired":false,"shares":3573545,"price":123.72,"value":442118987.4,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. (\"Group Advisors\"), (ii) TPG Advisors VI, Inc. (\"Advisors VI\"), (iii) TPG Advisors V, Inc. (\"Advisors V\") and (iv) TPG Biotech Advisors, Inc. (\"Biotech Advisors\" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Group Advisors is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC. TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., which directly holds 4,497,075 shares of Common Stock (\"Common Stock\") of IQVIA Holdings Inc. (the \"Issuer\"), (ii) TPG FOF V-A, L.P., which directly holds 11,765 shares of Common Stock, and (iii) TPG FOF V-B, L.P., which directly holds 9,486 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P., which directly holds 4,500,537 shares of Common Stock. TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P., which directly holds 185,685 shares of Common Stock. Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P., which directly holds 17,791 shares of Common Stock, and (ii) managing member of TPG Iceberg Co-Invest LLC, which directly holds 1,547,372 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Advisors V is the general partner of TPG Quintiles Holdco II, L.P., which directly holds 1,716,214 shares of Common Stock. Biotech Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the \"TPG Funds\"), which directly holds 89,806 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds. Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":12575731,"source":{"system":"sec-edgar","filing":"0000903423-18-000631","document":"iqvia.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860866/000090342318000631/iqvia.xml","form_type":"4"}},{"id":3889735,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":106747,"kind":"organization","name":"TPG Group Holdings (SBS) Advisors, Inc.","position":1,"cik":"0001495741","reported_name":"TPG Group Holdings (SBS) Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":136573,"kind":"organization","name":"TPG Advisors VI, Inc.","position":2,"cik":"0001433038","reported_name":"TPG Advisors VI, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":147565,"kind":"organization","name":"TPG Advisors V, Inc.","position":3,"cik":"0001425876","reported_name":"TPG Advisors V, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":147566,"kind":"organization","name":"TPG Biotech Advisors, Inc.","position":4,"cik":"0001666545","reported_name":"TPG Biotech Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":85655,"kind":"person","name":"BONDERMAN DAVID","position":5,"cik":"0000860866","reported_name":"BONDERMAN DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":24314,"kind":"person","name":"COULTER JAMES G","position":6,"cik":"0001099776","reported_name":"COULTER JAMES G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-19T16:21:09.000Z","date":"2018-06-15","kind":"sale","acquired":false,"shares":6716253,"price":103,"value":691774059.0,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. (\"Group Advisors\"), (ii) TPG Advisors VI, Inc. (\"Advisors VI\"), (iii) TPG Advisors V, Inc. (\"Advisors V\") and (iv) TPG Biotech Advisors, Inc. (\"Biotech Advisors\" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Group Advisors is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC. TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., which directly holds 5,774,974 shares of Common Stock (\"Common Stock\") of IQVIA Holdings Inc. (the \"Issuer\"), (ii) TPG FOF V-A, L.P., which directly holds 15,108 shares of Common Stock, and (iii) TPG FOF V-B, L.P., which directly holds 12,182 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P., which directly holds 5,779,419 shares of Common Stock. TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P., which directly holds 238,449 shares of Common Stock. Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P., which directly holds 22,846 shares of Common Stock, and (ii) managing member of TPG Iceberg Co-Invest LLC, which directly holds 1,987,076 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Advisors V is the general partner of TPG Quintiles Holdco II, L.P., which directly holds 2,203,897 shares of Common Stock. Biotech Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the \"TPG Funds\"), which directly holds 115,325 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds. Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":16149276,"source":{"system":"sec-edgar","filing":"0000903423-18-000351","document":"iqvia.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860866/000090342318000351/iqvia.xml","form_type":"4"}},{"id":4145146,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":106747,"kind":"organization","name":"TPG Group Holdings (SBS) Advisors, Inc.","position":1,"cik":"0001495741","reported_name":"TPG Group Holdings (SBS) Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":136573,"kind":"organization","name":"TPG Advisors VI, Inc.","position":2,"cik":"0001433038","reported_name":"TPG Advisors VI, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147565,"kind":"organization","name":"TPG Advisors V, Inc.","position":3,"cik":"0001425876","reported_name":"TPG Advisors V, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147566,"kind":"organization","name":"TPG Biotech Advisors, Inc.","position":4,"cik":"0001666545","reported_name":"TPG Biotech Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85655,"kind":"person","name":"BONDERMAN DAVID","position":5,"cik":"0000860866","reported_name":"BONDERMAN DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24314,"kind":"person","name":"COULTER JAMES G","position":6,"cik":"0001099776","reported_name":"COULTER JAMES G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-04T16:43:30.000Z","date":"2017-11-30","kind":"sale","acquired":false,"shares":5419971,"price":102,"value":552837042.0,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. (\"Group Advisors\"), (ii) TPG Advisors VI, Inc. (\"Advisors VI\"), (iii) TPG Advisors V, Inc. (\"Advisors V\") and (iv) TPG Biotech Advisors, Inc. (\"Biotech Advisors\" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Group Advisors is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC. TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., which directly holds 8,176,704 shares of Common Stock (\"Common Stock\") of IQVIA Holdings Inc. (the \"Issuer\"), (ii) TPG FOF V-A, L.P., which directly holds 21,391 shares of Common Stock, and (iii) TPG FOF V-B, L.P., which directly holds 17,248 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P., which directly holds 8,182,997 shares of Common Stock. TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P., which directly holds 337,616 shares of Common Stock. Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P., which directly holds 32,347 shares of Common Stock, and (ii) managing member of TPG Iceberg Co-Invest LLC, which directly holds 2,813,473 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Advisors V is the general partner of TPG Quintiles Holdco II, L.P., which directly holds 3,120,466 shares of Common Stock. Biotech Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the \"TPG Funds\"), which directly holds 163,287 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds. Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The TPG Funds have entered into a Shareholders Agreement, dated as of May 3, 2016 (as supplemented and amended, the \"Shareholders Agreement\"), with certain other holders (the \"Holders\") of shares of Common Stock. Because of the relationship between the TPG Funds and the Holders as a result of the Shareholders Agreement, the Reporting Persons may be deemed, pursuant to Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), to beneficially own the shares of Common Stock held in the aggregate by the Holders. Each Reporting Person and each TPG Fund disclaims beneficial ownership of the shares of Common Stock held by the Holders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":22865529,"source":{"system":"sec-edgar","filing":"0000903423-17-000710","document":"iqvia.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860866/000090342317000710/iqvia.xml","form_type":"4"}},{"id":4204422,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":106747,"kind":"organization","name":"TPG Group Holdings (SBS) Advisors, Inc.","position":1,"cik":"0001495741","reported_name":"TPG Group Holdings (SBS) Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":136573,"kind":"organization","name":"TPG Advisors VI, Inc.","position":2,"cik":"0001433038","reported_name":"TPG Advisors VI, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147565,"kind":"organization","name":"TPG Advisors V, Inc.","position":3,"cik":"0001425876","reported_name":"TPG Advisors V, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147566,"kind":"organization","name":"TPG Biotech Advisors, Inc.","position":4,"cik":"0001666545","reported_name":"TPG Biotech Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85655,"kind":"person","name":"BONDERMAN DAVID","position":5,"cik":"0000860866","reported_name":"BONDERMAN DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24314,"kind":"person","name":"COULTER JAMES G","position":6,"cik":"0001099776","reported_name":"COULTER JAMES G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-21T16:37:38.000Z","date":"2017-09-19","kind":"sale","acquired":false,"shares":4877974,"price":94.87,"value":462773393.38,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. (\"Group Advisors\"), (ii) TPG Advisors VI, Inc. (\"Advisors VI\"), (iii) TPG Advisors V, Inc. (\"Advisors V\") and (iv) TPG Biotech Advisors, Inc. (\"Biotech Advisors\" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Group Advisors is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC.  TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., which directly holds 10,114,884 shares of Common Stock (\"Common Stock\") of Quintiles IMS Holdings, Inc. (the \"Issuer\"), (ii) TPG FOF V-A, L.P., which directly holds 26,461 shares of Common Stock, and (iii) TPG FOF V-B, L.P., which directly holds 21,336 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P., which directly holds 10,122,667 shares of Common Stock.  TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P., which directly holds 417,644 shares of Common Stock.  Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P., which directly holds 40,015 shares of Common Stock, and (ii) managing member of TPG Iceberg Co-Invest LLC, which directly holds 3,480,370 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Advisors V is the general partner of TPG Quintiles Holdco II, L.P., which directly holds 3,860,131 shares of Common Stock.  Biotech Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the \"TPG Funds\"), which directly holds 201,992 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds.  Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The TPG Funds have entered into a Shareholders Agreement, dated as of May 3, 2016 (as supplemented and amended, the \"Shareholders Agreement\"), with certain other holders (the \"Holders\") of shares of Common Stock.  Because of the relationship between the TPG Funds and the Holders as a result of the Shareholders Agreement, the Reporting Persons may be deemed, pursuant to Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), to beneficially own the shares of Common Stock held in the aggregate by the Holders.  Each Reporting Person and each TPG Fund disclaims beneficial ownership of the shares of Common Stock held by the Holders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":28285500,"source":{"system":"sec-edgar","filing":"0000903423-17-000587","document":"quintiles.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860866/000090342317000587/quintiles.xml","form_type":"4"}},{"id":4222072,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":106747,"kind":"organization","name":"TPG Group Holdings (SBS) Advisors, Inc.","position":1,"cik":"0001495741","reported_name":"TPG Group Holdings (SBS) Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":136573,"kind":"organization","name":"TPG Advisors VI, Inc.","position":2,"cik":"0001433038","reported_name":"TPG Advisors VI, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147565,"kind":"organization","name":"TPG Advisors V, Inc.","position":3,"cik":"0001425876","reported_name":"TPG Advisors V, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147566,"kind":"organization","name":"TPG Biotech Advisors, Inc.","position":4,"cik":"0001666545","reported_name":"TPG Biotech Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85655,"kind":"person","name":"BONDERMAN DAVID","position":5,"cik":"0000860866","reported_name":"BONDERMAN DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24314,"kind":"person","name":"COULTER JAMES G","position":6,"cik":"0001099776","reported_name":"COULTER JAMES G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-08-30T16:48:38.000Z","date":"2017-08-28","kind":"sale","acquired":false,"shares":3772134,"price":97.33,"value":367141802.22,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. (\"Group Advisors\"), (ii) TPG Advisors VI, Inc. (\"Advisors VI\"), (iii) TPG Advisors V, Inc. (\"Advisors V\") and (iv) TPG Biotech Advisors, Inc. (\"Biotech Advisors\" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Group Advisors is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC.  TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., which directly holds 11,859,246 shares of Common Stock (\"Common Stock\") of Quintiles IMS Holdings, Inc. (the \"Issuer\"), (ii) TPG FOF V-A, L.P., which directly holds 31,024 shares of Common Stock, and (iii) TPG FOF V-B, L.P., which directly holds 25,016 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P., which directly holds 11,868,370 shares of Common Stock.  TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P., which directly holds 489,669 shares of Common Stock.  Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P., which directly holds 46,916 shares of Common Stock, and (ii) managing member of TPG Iceberg Co-Invest LLC, which directly holds 4,080,577 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Advisors V is the general partner of TPG Quintiles Holdco II, L.P., which directly holds 4,525,830 shares of Common Stock.  Biotech Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the \"TPG Funds\"), which directly holds 236,826 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds.  Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The TPG Funds have entered into a Shareholders Agreement, dated as of May 3, 2016 (as supplemented and amended, the \"Shareholders Agreement\"), with certain other holders (the \"Holders\") of shares of Common Stock.  Because of the relationship between the TPG Funds and the Holders as a result of the Shareholders Agreement, the Reporting Persons may be deemed, pursuant to Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), to beneficially own the shares of Common Stock held in the aggregate by the Holders.  Each Reporting Person and each TPG Fund disclaims beneficial ownership of the shares of Common Stock held by the Holders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":33163474,"source":{"system":"sec-edgar","filing":"0000903423-17-000563","document":"quintiles.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860866/000090342317000563/quintiles.xml","form_type":"4"}},{"id":4296910,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":106747,"kind":"organization","name":"TPG Group Holdings (SBS) Advisors, Inc.","position":1,"cik":"0001495741","reported_name":"TPG Group Holdings (SBS) Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":136573,"kind":"organization","name":"TPG Advisors VI, Inc.","position":2,"cik":"0001433038","reported_name":"TPG Advisors VI, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147565,"kind":"organization","name":"TPG Advisors V, Inc.","position":3,"cik":"0001425876","reported_name":"TPG Advisors V, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147566,"kind":"organization","name":"TPG Biotech Advisors, Inc.","position":4,"cik":"0001666545","reported_name":"TPG Biotech Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85655,"kind":"person","name":"BONDERMAN DAVID","position":5,"cik":"0000860866","reported_name":"BONDERMAN DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24314,"kind":"person","name":"COULTER JAMES G","position":6,"cik":"0001099776","reported_name":"COULTER JAMES G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-06-02T16:46:31.000Z","date":"2017-05-31","kind":"sale","acquired":false,"shares":5154936,"price":84.01,"value":433066173.36,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. (\"Group Advisors\"), (ii) TPG Advisors VI, Inc. (\"Advisors VI\"), (iii) TPG Advisors V, Inc. (\"Advisors V\") and (iv) TPG Biotech Advisors, Inc. (\"Biotech Advisors\" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Group Advisors is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC.  TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., which directly holds 13,208,160 shares of Common Stock (\"Common Stock\") of Quintiles IMS Holdings, Inc. (the \"Issuer\"), (ii) TPG FOF V-A, L.P., which directly holds 34,553 shares of Common Stock, and (iii) TPG FOF V-B, L.P., which directly holds 27,861 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P., which directly holds 13,218,321 shares of Common Stock.  TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P., which directly holds 545,366 shares of Common Stock.  Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P., which directly holds 52,252 shares of Common Stock, and (ii) managing member of TPG Iceberg Co-Invest LLC, which directly holds 4,544,717 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Advisors V is the general partner of TPG Quintiles Holdco II, L.P., which directly holds 5,040,614 shares of Common Stock.  Biotech Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the \"TPG Funds\"), which directly holds 263,764 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds.  Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The TPG Funds have entered into a Shareholders Agreement, dated as of May 3, 2016 (as supplemented and amended, the \"Shareholders Agreement\"), with certain other holders (the \"Holders\") of shares of Common Stock.  Because of the relationship between the TPG Funds and the Holders as a result of the Shareholders Agreement, the Reporting Persons may be deemed, pursuant to Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), to beneficially own the shares of Common Stock held in the aggregate by the Holders.  Each Reporting Person and each TPG Fund disclaims beneficial ownership of the shares of Common Stock held by the Holders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":36935608,"source":{"system":"sec-edgar","filing":"0000903423-17-000408","document":"quintiles.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860866/000090342317000408/quintiles.xml","form_type":"4"}},{"id":4411786,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":106747,"kind":"organization","name":"TPG Group Holdings (SBS) Advisors, Inc.","position":1,"cik":"0001495741","reported_name":"TPG Group Holdings (SBS) Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":136573,"kind":"organization","name":"TPG Advisors VI, Inc.","position":2,"cik":"0001433038","reported_name":"TPG Advisors VI, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147565,"kind":"organization","name":"TPG Advisors V, Inc.","position":3,"cik":"0001425876","reported_name":"TPG Advisors V, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147566,"kind":"organization","name":"TPG Biotech Advisors, Inc.","position":4,"cik":"0001666545","reported_name":"TPG Biotech Advisors, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85655,"kind":"person","name":"BONDERMAN DAVID","position":5,"cik":"0000860866","reported_name":"BONDERMAN DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24314,"kind":"person","name":"COULTER JAMES G","position":6,"cik":"0001099776","reported_name":"COULTER JAMES G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-03-02T17:07:49.000Z","date":"2017-02-28","kind":"disposition_to_issuer","acquired":false,"shares":7561013,"price":77.5,"value":585978507.5,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. (\"Group Advisors\"), (ii) TPG Advisors VI, Inc. (\"Advisors VI\"), (iii) TPG Advisors V, Inc. (\"Advisors V\") and (iv) TPG Biotech Advisors, Inc. (\"Biotech Advisors\" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Group Advisors is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC. TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., which directly holds 15,051,563 shares of Common Stock (\"Common Stock\") of Quintiles IMS Holdings, Inc. (the \"Issuer\"), (ii) TPG FOF V-A, L.P., which directly holds 39,375 shares of Common Stock, and (iii) TPG FOF V-B, L.P., which directly holds 31,750 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P., which directly holds 15,063,142 shares of Common Stock. TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P., which directly holds 621,480 shares of Common Stock. Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P., which directly holds 59,545 shares of Common Stock, and (ii) managing member of TPG Iceberg Co-Invest LLC, which directly holds 5,179,003 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Advisors V is the general partner of TPG Quintiles Holdco II, L.P., which directly holds 5,744,110 shares of Common Stock. Biotech Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the \"TPG Funds\"), which directly holds 300,576 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds. Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The TPG Funds have entered into a Shareholders Agreement, dated as of May 3, 2016 (as supplemented and amended, the \"Shareholders Agreement\"), with certain other holders (the \"Holders\") of shares of Common Stock. Because of the relationship between the TPG Funds and the Holders as a result of the Shareholders Agreement, the Reporting Persons may be deemed, pursuant to Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), to beneficially own the shares of Common Stock held in the aggregate by the Holders. Each Reporting Person and each TPG Fund disclaims beneficial ownership of the shares of Common Stock held by the Holders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":42090544,"source":{"system":"sec-edgar","filing":"0000903423-17-000161","document":"quintiles.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860866/000090342317000161/quintiles.xml","form_type":"4"}},{"id":4585351,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":106747,"kind":"organization","name":"TPG Group Holdings (SBS) Advisors, Inc.","position":1,"cik":"0001495741","reported_name":"TPG Group Holdings (SBS) Advisors, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":136573,"kind":"organization","name":"TPG Advisors VI, Inc.","position":2,"cik":"0001433038","reported_name":"TPG Advisors VI, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147565,"kind":"organization","name":"TPG Advisors V, Inc.","position":3,"cik":"0001425876","reported_name":"TPG Advisors V, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147566,"kind":"organization","name":"TPG Biotech Advisors, Inc.","position":4,"cik":"0001666545","reported_name":"TPG Biotech Advisors, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":85655,"kind":"person","name":"BONDERMAN DAVID","position":5,"cik":"0000860866","reported_name":"BONDERMAN DAVID","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24314,"kind":"person","name":"COULTER JAMES G","position":6,"cik":"0001099776","reported_name":"COULTER JAMES G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T17:14:09.000Z","date":"2016-10-03","kind":"other","acquired":true,"shares":42521023,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities reported herein were acquired pursuant to the Agreement and Plan of Merger, dated as of May 3, 2016 (the \"Merger Agreement\"), by and among IMS Health Holdings, Inc. (\"IMS\") and Quintiles Transnational Holdings Inc. (the \"Issuer\"), whereby IMS merged with and into the Issuer with the Issuer surviving the merger (the \"Merger\"). At the effective time of the Merger, each share of Common Stock of IMS (the \"IMS Shares\"), issued and outstanding immediately prior to such time (other than IMS Shares held by IMS in treasury or owned by the Issuer or any of their direct or indirect subsidiaries) was cancelled and ceased to exist and was converted into the right to receive 0.3840 of validly issued, fully paid and non-assessable shares of Common Stock of the Issuer, par value $0.01 per share (the \"Issuer Shares\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities reported herein were acquired pursuant to the Agreement and Plan of Merger, dated as of May 3, 2016 (the \"Merger Agreement\"), by and among IMS Health Holdings, Inc. (\"IMS\") and Quintiles Transnational Holdings Inc. (the \"Issuer\"), whereby IMS merged with and into the Issuer with the Issuer surviving the merger (the \"Merger\"). At the effective time of the Merger, each share of Common Stock of IMS (the \"IMS Shares\"), issued and outstanding immediately prior to such time (other than IMS Shares held by IMS in treasury or owned by the Issuer or any of their direct or indirect subsidiaries) was cancelled and ceased to exist and was converted into the right to receive 0.3840 of validly issued, fully paid and non-assessable shares of Common Stock of the Issuer, par value $0.01 per share (the \"Issuer Shares\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. (\"Group Advisors\"), (ii) TPG Advisors VI, Inc. (\"Advisors VI\"), (iii) TPG Advisors V, Inc. (\"Advisors V\") and (iv) TPG Biotech Advisors, Inc. (\"Biotech Advisors\" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Group Advisors is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC. TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., which directly holds 17,755,378 Issuer Shares, (ii) TPG FOF V-A, L.P., which directly holds 46,448 Issuer Shares, and (iii) TPG FOF V-B, L.P., which directly holds 37,454 Issuer Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P., which directly holds 17,769,038 Issuer Shares. TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P., which directly holds 733,121 Issuer Shares. Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P., which directly holds 70,241 Issuer Shares, and (ii) managing member of TPG Iceberg Co-Invest LLC, which directly holds 6,109,343 Issuer Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Advisors V is the general partner of TPG Quintiles Holdco II, L.P., which directly holds 6,775,964 Issuer Shares. Biotech Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the \"TPG Funds\"), which directly holds 354,570 Issuer Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds. Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The TPG Funds have entered into a Shareholders Agreement, dated as of May 3, 2016 (as supplemented and amended, the \"Shareholders Agreement\"), with certain other holders (the \"Holders\") of Issuer Shares. Because of the relationship between the TPG Funds and the Holders as a result of the Shareholders Agreement, the Reporting Persons may be deemed, pursuant to Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), to beneficially own the Issuer Shares held in the aggregate by the Holders. Each Reporting Person and each TPG Fund disclaims beneficial ownership of the Issuer Shares held by the Holders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."}],"balance_after":49651557,"source":{"system":"sec-edgar","filing":"0000903423-16-001293","document":"tpgsbq4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/860866/000090342316001293/tpgsbq4.xml","form_type":"4"}}]}